Skip to main content
Premium Trial:

Request an Annual Quote

Cogenics Using 454 Sequencing in Crop Collaboration

NEW YORK (GenomeWeb News) – Cogenics and Roche subsidiary 454 Life Sciences will collaborate to develop SNPs for the plant breeder Limagrain that could be used to engineer better crops including wheat, Cogenics’ parent company Clinical Data said today.
Under the agreement, Cogenics will develop a genome complexity reduction assay to select gene-rich portions of a crop genome across multiple variants of the species.
Clinical Data said Cogenics will work with 454 to sequence around 2Gb of the wheat genome using the GS-FLX sequencer. The sequencing is the first step in a two-stage process, through which the companies will identify molecular markers linked with desirable characteristics.
Jean-Pierre Martinant, who heads a genotyping facility of Limagrain Verneuil Holding in France, said the collaboration with Cogenics and 454 “will significantly enhance our ability to accelerate the large scale genotyping campaigns required to meet the goals of this project.”
Financial terms of the agreement were not released.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.